Phase II Study of S-1 Combined With Low-Dose Docetaxel as Neoadjuvant Chemotherapy for Operable Breast Cancer Patients (N-1 Study)
Article in Clinical Breast Cancer (September 2018)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Nucleoside diphosphate kinase 2 confers acquired 5-fluorouracil resistance in colorectal cancer cells
Article in Artificial Cells Nanomedicine and Biotechnology (February 2018)
ADAM12-L confers acquired 5-fluorouracil resistance in breast cancer cells
Article in Scientific Reports (August 2017)